SEC Form 4/A · accession 0000874015-18-000033
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Stanley T Crooke
Officer — Chairman and CEO · Director
Period of report
Jan 29, 2018
Accepted (ET)
Jan 31, 2018 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 29, 2018 | M | 10,000 | $14.69 | A | 61,733 | D | |
| Common StockF1 | Jan 29, 2018 | S | 10,000 | $54.12 | D | 51,733 | D | |
| Common StockF2 | Jan 29, 2018 | M | 1,000 | $10.82 | A | 5,128 | I | By wife |
| Common StockF2 | Jan 29, 2018 | S | 1,000 | $54.12 | D | 4,128 | I | By wife |
| Common Stock | holding | — | — | — | 725,391 | I | By trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $14.69 | Jan 29, 2018 | M | 10,000 | D | Jan 2, 2017 | Jan 29, 2020 | Common Stock | 10,000 | 26,642 | D |
| Employee Stock Option (right to buy) | $10.82 | Jan 29, 2018 | M | 1,000 | D | Jan 2, 2017 | Jan 1, 2020 | Common Stock | 1,000 | 6,904 | I |
Explanation of responses
- F1Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 6/20/2016.
- F2Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person's wife on 6/17/2016.